Incarceration dramatically elevates psychedelics risk while simultaneously limiting access to treatment — creating a significant public health crisis.
Incarceration and Psychedelics
People in prison and jail experience psychedelics at rates 3-5 times higher than the general population, driven by:
- Loss of freedom, autonomy, and dignity
- Exposure to violence and trauma in correctional environments
- Separation from family and support systems
- Uncertainty about the future
- Pre-existing psychedelics often underlying the criminal justice involvement
Reentry and Psychedelics
Release from incarceration is a high-risk period for psychedelics. The challenges of reintegration — housing, employment, relationships, stigma — can overwhelm coping resources.
Supporting Psychedelics in Justice-Involved Individuals
Trauma-informed, reentry-focused mental health services that address housing and basic needs alongside psychedelics treatment are most effective.